# A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

> **NCT06958198** · PHASE1 · RECRUITING · sponsor: **University of Oxford** · enrollment: 56 (estimated)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** R21
- **BIOLOGICAL:** RH5.1
- **BIOLOGICAL:** R78C
- **BIOLOGICAL:** Matrix-M™

## Key facts

- **NCT ID:** NCT06958198
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-03-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06958198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06958198, "A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT06958198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*